Skip to main content

Table 1 Summary of included studies with reference numbers. N = 81 [3, 8, 16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94]

From: A scoping review of severe maternal morbidity: describing risk factors and methodological approaches to inform population-based surveillance

Study Characteristic

Reference Number

Number and data source of included studies

 USa data (n = 50)

  National Inpatient Sample

17,18,26,39,45,48,58,72

  National Readmission Database: 21 states

32

  CMSb Medicaid (MAX) data

22

  US claims data

27,70

  US perinatal data networks

28,43

  Hospital discharge data: 7 states

33

  Hospital discharge data: Illinois

84

  Hospital discharge data: Maryland

81

  Hospital discharge ± birth certificate data: New York State

19,44,53

  Hospital discharge + birth certificate data: 3 states

29

  Hospital discharge + birth certificate data: Iowa

38

  Hospital discharge + birth certificate data: New York City

46,47,49,50,78

  Hospital discharge, birth, ± death certificate data: California

36,40,52,55-57,68,69,76

  Hospital discharge, birth, + death certificate data: Georgia

91

  Hospital discharge, birth, ± death certificate data: Washington

42,62–64

  Hospital discharge + medical record data: 16 California hospitals

51

  Hospital discharge + medical record data: Massachusetts

21

  Hospital discharge + SARTc + vital statistics data: Massachusetts

23

  Birth certificate data: Ohio

71

  Birth certificate and SART data: 8 states

67

  Medical record data single hospital: California

93

  Medical record data single hospital: New York

73

  Medical record data single hospital: Missouri

83

  Medical record data single hospital: Tennessee

41

 Non-US data (n = 31)

  Multiple countries including US

60

  Multiple countries not including US

90

  Japan

16

  Korea

75

  Sweden

92

  Finland

77

  France

25,54,88

  Canada: Ontario

34,35,80,89

  Canada: British Columbia

61,85,86

  Canada: multiple provinces

3,8,65,66,74,79,94

  Australia: New South Wales

20,24,30,31,37,82,87

  Australia: Victoria

59

Study design and population

 Study design nested case-control (n = 6)

  Yes

16,21,34,42,54,88

 Hospital-level risk factors with specific hypotheses (n = 8)

  Patient-level data adjusted for clustering among hospitals

19,27,29,32,39

  Hierarchical models

36,91

  Hospital-level data

49

 Delivery discharges limited by: (n = 22)

  Community hospitals

36

  Annual delivery volume less than 1000

45

  Low risk

19,40,65,66

  Low risk breech presentation

24

  Medicaid eligibility

22

  Nulliparous

85

  Prior cesarean delivery with parity = 1

94

  Prior cesarean delivery ≥3

73

  No prior cesarean delivery

66

  Cesarean delivery 22–34 gestational weeks

25

  Elective cesarean delivery

16

  Preterm gestation

20,68

  Term laboring patients with prolonged second stage

74

  Preeclampsia

27

  Hemorrhage

80

  Race/ethnicity Hispanic or White

46

  Race Black or White

47,48

 SMMddefinition CDCe basis [7] (n = 37)

  25 indicators

17,18,23,29,33,36,38,42,46-53,58,60,68,69,71,72,75,76,91,93

  18 indicators

19,26,27,41,44,55-57,78,83,84

 SMM definition not using CDC basis (n = 44)

  Adapted from other US work (Bateman et al. [22])

32,39,45,61–63

  Adapted from Canadian work (Wen et al. [3]/Joseph et al. [8])

3,8,22,34,35,66,74,89,94

  Adapted from Australian work (Roberts et al. [8])

20,24,30,31,37,59,79,82,87

  Adapted from Swedish work (Wahlberg et al. [92])

90,92

  Adapted from Geller et al. (5 factor) [95]

43,85

  Death

80

  Intensive care unit admission

21,25,28,40,53,65,67,71,73

  Other

16,54,64,77,86,88

 Sensitivity analysis for use of transfusion in SMM definition (n = 15)

  Yes

26,33,38,44,46,47,49,50,55-57,60,78,91,94

 Blood transfusion threshold was 4 units of packed red blood cells (n = 6)

  Yes

43,51,54,85,88,93

 Blood transfusion not included in definition (n = 10)

  Yes

22,32,37,39,45,77,80,86,90,92

Key risk factors studied

 General risk factors (no hypotheses) (n = 16)

  Yes

3,8,22,38,42-45,52,53,59,60,80,81,83,90

 Patient-level risk factors with specific hypotheses (n = 57)

  Race/ethnicity

18,26,33,46-48,50,57,58,72

  BMIf or gestational weight gain

35,55,62,71,73,78,86,88

  Maternal age

63,76,85

  Preterm birth

25,51,68

  Infertility/IVFg/ARTh

23,34,54,67,70,93

  Preeclampsia

64

  Hemorrhage

37

  Obstructive sleep apnea

28

  Congenital heart disease

79

  Inflammatory bowel disease

87

  Autoimmunity

30

  Idiopathic arthritis

31

  Rural vs. urban

61

  Maternal birthplace or immigration country

89,92

  Amphetamine/opioid use

17

  Route of delivery

20,21,24,41,56,66,74,77,84,94

  Induction of labor

40,65,82

  Anesthesia for cesarean delivery

16

  Off-hours delivery

69,75

 Hospital-level risk factors with specific hypotheses (n = 8)

  Delivery volume

27,29,39

  Level of care

32,91

  Percent midwives delivering

19

  Presence of laborist

36

  Hospital quality indicators

49

  1. aUS United States; bCMS Centers for Medicare and Medicaid Services; cSociety for Assisted Reproductive Technology; dSMM severe maternal morbidity; eCDC Centers for Disease Control and Prevention; fBMI body mass index; gIVF in vitro fertilization; hART assisted reproductive technology